Room air

PreclinicalBiologic

MMassachusetts General Hospital

Room air is one of 4 biologic programs targeting Heart. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

HeartCompleted

HeartPreclinical

Completed

Competition

Competitive Landscape

5 competitors in Heart

#DrugCompanyPhaseTrials

Ephedrine Sulfate

DDr. Reddys Laboratories, SA

Approved

1 2

Sudafed

KKenvue Brands

Preclinical

1 3

Glucagon Like Peptide-1

UUniversity Hospital, Gentofte, Copenhagen

Preclinical

1 4

Room air

MMassachusetts General Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

Phase 2Recruiting

Nitrous Oxide

NCT06118567

Clinical

Trials by Indication[1]

Migraine1 trial

Normobaric Oxygen (NBO) Therapy in Acute Migraine

Completed·MMassachusetts General Hospital·Phase 2·NCT01542307·22 enrolled

Ischemic stroke1 trial

Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial

Terminated·MMassachusetts General Hospital·Phase 2·NCT00414726·85 enrolled

Nitrous Oxide1 trial

Effect of Nitrous Oxide on Aggression.

Recruiting·OOhio State University·Phase 2·NCT06118567·50 enrolled

Heart1 trial

Oxygen for Intrauterine Resuscitation of Category II Fetal Heart Tracings

Completed·WWashington University School of Medicine·N/A·NCT02741284·114 enrolled

Pulmonary Hypertension1 trial

A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia

Withdrawn·DDuke University·Preclinical·NCT06327373

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Room air. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Room air compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Room air. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Massachusetts General Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: MMassachusetts General Hospital

Room air

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Trials by Indication[1]

Migraine1 trial

Ischemic stroke1 trial

Nitrous Oxide1 trial

Heart1 trial

Pulmonary Hypertension1 trial

References

Drug Info

Quick Facts

Related News